DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION

Patent Applications and Registrations

Patent applications and USPTO patent grants for DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION.The latest application filed is for "pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer".

Company Profile

11.12.10

DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION - Daegu KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition Comprising Trimebutine or Pharmaceutically Acceptable Salt Thereof as an Active Ingredient For Prevention or Treatment of Cancer App 20220193020 - KIM; Jun Woo ; et al.	2022-06-23
Pyrrolo-pyridine Derivative Compound, Method For Preparing Same, And Pharmaceutical Composition Containing Same As Active Ingredient For Prevention Or Treatment Of Protein Kinase-related Diseases App 20220106307 - CHOI; Hwan Geun ; et al.	2022-04-07
Aryl ethene derivative and pharmaceutical composition containing same as active ingredient Grant 11,285,226 - Hwang , et al. March 29, 2	2022-03-29
Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease Grant 11,208,412 - Choi , et al. December 28, 2	2021-12-28
Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseases Grant 11,117,892 - Choi , et al. September 14, 2	2021-09-14
Transmitting/receiving Dual-mode Focused Ultrasonic Transducer And Microbubble Cavitation Image Visualization Method Using Same App 20210278515 - PARK; Juyoung ; et al.	2021-09-09
Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer App 20210267997 - Choi; Hwan Geun ; et al.	2021-09-02
Multi-channel Ultrasound Stimulator App 20210196988 - PARK; Juyoung ; et al.	2021-07-01
Aryl ethene derivative and pharmaceutical composition containing same as active ingredient Grant 10,934,303 - Hwang , et al. March 2, 2	2021-03-02
Imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer Grant 10,870,647 - Choi , et al. December 22, 2	2020-12-22
Pyrrolo-pyrimidine Derivative Compound, Preparation Method Therefor, And Pharmaceutical Composition Comprising Same Compound As App 20200239474 - CHOI; Hwan Geun ; et al.	2020-07-30
Pyrrolo-pyridine Derivative Compound, Method For Preparing Same, And Pharmaceutical Composition Containing Same As Active Ingredient For Prevention Or Treatment Of Protein Kinase-related Diseases App 20200207756A1 -	2020-07-02
Novel Imidazopyridine Derivative, Method For Preparing Same, And Pharmaceutical Composition Containing Same As Active Ingredient App 20190315738 - Choi; Hwan Geun ; et al.	2019-10-17
2,3,5-substituted thiophene compound as protein kinase inhibitor Grant 10,442,796 - Sim , et al. Oc	2019-10-15
Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor App 20190047993 - Sim; Tae Bo ; et al.	2019-02-14
Bifunctional Compounds For Her3 Degradation And Methods Of Use App 20190016703 - GRAY; Nathanael S. ; et al.	2019-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.